1. Identification and bioactivity evaluation of twelve previously undescribed depsidone derivatives from Garcinia oligantha.
- Author
-
Peng XH, Chen S, Liu XF, Yang JY, Meng FZ, Cao H, Li DH, and Hua HM
- Subjects
- Humans, Molecular Structure, Structure-Activity Relationship, Dose-Response Relationship, Drug, Cell Line, Tumor, Plant Leaves chemistry, Garcinia chemistry, Cell Proliferation drug effects, Antineoplastic Agents, Phytogenic pharmacology, Antineoplastic Agents, Phytogenic chemistry, Antineoplastic Agents, Phytogenic isolation & purification, Drug Screening Assays, Antitumor, Apoptosis drug effects, Depsides chemistry, Depsides pharmacology, Depsides isolation & purification, Lactones chemistry, Lactones pharmacology, Lactones isolation & purification
- Abstract
Phytochemical studies on the leaves and twigs of Garcinia oligantha Merr. led to the isolation of twelve previously undescribed depsidone derivatives (oliganthdepsidones A-L, 1-12). Their structures were elucidated by extensive spectroscopic analysis including
1 H and13 C NMR, HSQC, HMBC and NOESY along with HRESIMS. The structures of oliganthdepsidones G and J were finally determined using DFT-NMR chemical shift calculations and DP4+ methods. Cytotoxicity test in four human cancer cell lines indicated that oliganthdepsidone F had relatively strong cytotoxic effect against A375 (melanoma), A549 (lung cancer), HepG2 (liver cancer), and MCF-7 (breast cancer) cell lines with IC50 of 18.71, 15.44, 10.92, and 15.90 μM, respectively. The dose- and time-dependent antiproliferative effects of oliganthdepsidone F on these cell lines were also observed by CCK-8 test. As determined by fluorescent microscopy and flow cytometry in these cell lines, oliganthdepsidone F could promote cell apoptosis, leading to the inhibition of cell proliferation. The results of wound healing assay and transwell assay showed that oliganthdepsidone F could inhibit the migration and invasion of A549 and MCF-7 cell lines in a concentration-dependent manner., Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2024 Elsevier Ltd. All rights reserved.)- Published
- 2024
- Full Text
- View/download PDF